Grant Number:	5R01CA096670-05 Interpret this number
Primary Investigator:	Bhatia, Smita
Organization:	Beckman Research Institute/City Of Hope
Project Title:	Ethnic Differences in Survival After Childhood All
Fiscal Year:	2008

DESCRIPTION (provided by applicant): Acute lymphoblastic leukemia (ALL) is the most common childhood malignancy, with a five-year survival rate approaching 80%. We have shown highly significant differences in survival among ethnic and racial groups. The remission rates were comparable among the four ethnic and racial groups (97% to 99%) studied, but the relapse rates were significantly different, resulting in the observed difference in Event-Free Survival (EFS). African-American children had the poorest and Asians the best outcome. The outcome for Hispanics was intermediate between that for Caucasians and African-Americans. Multivariate analysis revealed racial/ethnic background to be independently associated with decreased EFS, even after controlling for known risk factors such as age at diagnosis, high initial white count and chromosomal abnormalities associated with adverse outcomes. Thus, follow-up of this large cohort of 8,447 patients documents that survival rates after ALL are significantly different for children from different ethnic and racial backgrounds. The reason(s) for the observed differences in outcome by ethnicity are not clear. Treatment of ALL requires a maintenance phase of approximately two years composed of oral administration of antimetabolites [6-Mercaptopurine (6MP) and methotrexate (MTX)] in order to achieve durable remissions. Low systemic exposure to oral 6MP during maintenance therapy (represented by red cell antimetabolite concentrations) has been shown to adversely affect prognosis. There is significant inter-patient variability in red cell 6MP metabolite levels that could stem from differences in the rates of absorption, metabolism, or elimination of 6MP, or because of failure to adhere to therapy. We hypothesize that ethnic/racial difference in systemic exposure to 6MP during maintenance therapy, due primarily to non-adherence to 6MP, could explain the observed differences in outcome of childhood ALL by race/ethnicity. We aim to i) determine adherence to 6MP in a cohort of children with ALL from four different ethnic and racial groups (Caucasians, African-Americans, Hispanics, and Asians) receiving maintenance chemotherapy. Adherence will be assessed by measuring red cell 6MP metabolites (6TGN, MethylTIMP), frequency of 6MP dosing using an electronic pill monitoring system (MEMS), and self report of adherence to 6MP; ii) determine the impact of adherence to 6MP on EFS in the entire cohort studied, after adjusting for known predictors of disease outcome; iii) define a critical level of adherence (measured independently by 6TGN, MEMS, self-report) that has a significant impact on EFS for the entire cohort; iv) using the definition from (iii), describe prevalence of adherence to 6MP by ethnicity; v) describe behavioral and socio-demographic predictors of adherence using the questionnaire data; vi) describe the pill-taking practices in this cohort using the MEMS data; and vii) evaluate the impact of adherence on ethnic/racial difference in EFS. We will control for polymorphisms in TPMT, and other genetic polymorphisms (in transporters, repair enzymes, HPRT, etc.), as well as control for potential differences in disease burden and biology among the ethnic groups. Our overall goal is to conduct a comprehensive study across ethnic groups to elucidate the reasons for the observed differences in survival by race and ethnicity, thus building a framework for appropriate intervention(s) to address this problem in the future.




Clinical Actionability of the NUDT15 *4 (p.R139H) Allele and Its Association With Hispanic Ethnicity.
Authors: Maillard M. , Nguyen J.Q. , Yang W. , Hoshitsuki K. , Relling M.V. , Caudle K.E. , Crews K.R. , Jeha S. , Inaba H. , Pui C.H. , et al. .
Source: Clinical Pharmacology And Therapeutics, 2024-12-17 00:00:00.0; , .
EPub date: 2024-12-17 00:00:00.0.
PMID: 39688234
Related Citations

Poverty and relapse risk in children with acute lymphoblastic leukemia: a Children's Oncology Group study AALL03N1 report.
Authors: Wadhwa A. , Chen Y. , Hageman L. , Hoppmann A. , Angiolillo A. , Dickens D.S. , Neglia J.P. , Ravindranath Y. , Ritchey A.K. , Termuhlen A. , et al. .
Source: Blood, 2023-07-20 00:00:00.0; 142(3), p. 221-229.
PMID: 37070673
Related Citations

Body mass index during maintenance therapy and relapse risk in children with acute lymphoblastic leukemia: A Children's Oncology Group report.
Authors: Wadhwa A. , Chen Y. , Hageman L. , Hoppmann A.L. , Angiolillo A. , Dickens D.S. , Lew G. , Neglia J.P. , Ravindranath Y. , Ritchey A.K. , et al. .
Source: Cancer, 2022-11-12 00:00:00.0; , .
EPub date: 2022-11-12 00:00:00.0.
PMID: 36369905
Related Citations

Comprehensive characterization of pharmacogenetic variants in TPMT and NUDT15 in children with acute lymphoblastic leukemia.
Authors: Moriyama T. , Yang W. , Smith C. , Pui C.H. , Evans W.E. , Relling M.V. , Bhatia S. , Yang J.J. .
Source: Pharmacogenetics And Genomics, 2022-02-01 00:00:00.0; 32(2), p. 60-66.
PMID: 34412101
Related Citations

Individual prediction of nonadherence to oral mercaptopurine in children with acute lymphoblastic leukemia: Results from COG AALL03N1.
Authors: Hoppmann A.L. , Chen Y. , Landier W. , Hageman L. , Evans W.E. , Wong F.L. , Relling M.V. , Bhatia S. .
Source: Cancer, 2021-06-23 00:00:00.0; , .
EPub date: 2021-06-23 00:00:00.0.
PMID: 34161608
Related Citations

Effects of NT5C2 Germline Variants on 6-Mecaptopurine Metabolism in Children With Acute Lymphoblastic Leukemia.
Authors: Jiang C. , Yang W. , Moriyama T. , Liu C. , Smith C. , Yang W. , Qian M. , Li Z. , Tulstrup M. , Schmiegelow K. , et al. .
Source: Clinical Pharmacology And Therapeutics, 2020-10-29 00:00:00.0; , .
EPub date: 2020-10-29 00:00:00.0.
PMID: 33124053
Related Citations

Massively parallel variant characterization identifies NUDT15 alleles associated with thiopurine toxicity.
Authors: Suiter C.C. , Moriyama T. , Matreyek K.A. , Yang W. , Scaletti E.R. , Nishii R. , Yang W. , Hoshitsuki K. , Singh M. , Trehan A. , et al. .
Source: Proceedings Of The National Academy Of Sciences Of The United States Of America, 2020-03-10 00:00:00.0; 117(10), p. 5394-5401.
EPub date: 2020-02-24 00:00:00.0.
PMID: 32094176
Related Citations

Multiplex assessment of protein variant abundance by massively parallel sequencing.
Authors: Matreyek K.A. , Starita L.M. , Stephany J.J. , Martin B. , Chiasson M.A. , Gray V.E. , Kircher M. , Khechaduri A. , Dines J.N. , Hause R.J. , et al. .
Source: Nature Genetics, 2018 Jun; 50(6), p. 874-882.
EPub date: 2018-05-21 00:00:00.0.
PMID: 29785012
Related Citations

Mercaptopurine Ingestion Habits, Red Cell Thioguanine Nucleotide Levels, and Relapse Risk in Children With Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group Study AALL03N1.
Authors: Landier W. , Hageman L. , Chen Y. , Kornegay N. , Evans W.E. , Bostrom B.C. , Casillas J. , Dickens D.S. , Angiolillo A.L. , Lew G. , et al. .
Source: Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology, 2017-05-20 00:00:00.0; 35(15), p. 1730-1736.
EPub date: 2017-03-24 00:00:00.0.
PMID: 28339328
Related Citations

Comparison of self-report and electronic monitoring of 6MP intake in childhood ALL: a Children's Oncology Group study.
Authors: Landier W. , Chen Y. , Hageman L. , Kim H. , Bostrom B.C. , Casillas J.N. , Dickens D.S. , Evans W.E. , Maloney K.W. , Mascarenhas L. , et al. .
Source: Blood, 2017-04-06 00:00:00.0; 129(14), p. 1919-1926.
EPub date: 2017-04-06 00:00:00.0.
PMID: 28153823
Related Citations

Optimizing Medication Adherence In Children With Cancer
Authors: Gupta S. , Bhatia S. .
Source: Current Opinion In Pediatrics, 2017 Feb; 29(1), p. 41-45.
PMID: 27798425
Related Citations

Systemic Exposure to Thiopurines and Risk of Relapse in Children With Acute Lymphoblastic Leukemia: A Children's Oncology Group Study.
Authors: Bhatia S. , Landier W. , Hageman L. , Chen Y. , Kim H. , Sun C.L. , Kornegay N. , Evans W.E. , Angiolillo A.L. , Bostrom B. , et al. .
Source: Jama Oncology, 2015 Jun; 1(3), p. 287-95.
PMID: 26181173
Related Citations

Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia.
Authors: Yang J.J. , Landier W. , Yang W. , Liu C. , Hageman L. , Cheng C. , Pei D. , Chen Y. , Crews K.R. , Kornegay N. , et al. .
Source: Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology, 2015-04-10 00:00:00.0; 33(11), p. 1235-42.
EPub date: 2015-04-10 00:00:00.0.
PMID: 25624441
Related Citations

6MP adherence in a multiracial cohort of children with acute lymphoblastic leukemia: a Children's Oncology Group study.
Authors: Bhatia S. , Landier W. , Hageman L. , Kim H. , Chen Y. , Crews K.R. , Evans W.E. , Bostrom B. , Casillas J. , Dickens D.S. , et al. .
Source: Blood, 2014-10-09 00:00:00.0; 124(15), p. 2345-53.
EPub date: 2014-10-09 00:00:00.0.
PMID: 24829202
Related Citations

Nonadherence to oral mercaptopurine and risk of relapse in Hispanic and non-Hispanic white children with acute lymphoblastic leukemia: a report from the children's oncology group.
Authors: Bhatia S. , Landier W. , Shangguan M. , Hageman L. , Schaible A.N. , Carter A.R. , Hanby C.L. , Leisenring W. , Yasui Y. , Kornegay N.M. , et al. .
Source: Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology, 2012-06-10 00:00:00.0; 30(17), p. 2094-101.
EPub date: 2012-06-10 00:00:00.0.
PMID: 22564992
Related Citations

Disparities in cancer outcomes: lessons learned from children with cancer.
Authors: Bhatia S. .
Source: Pediatric Blood & Cancer, 2011 Jun; 56(6), p. 994-1002.
PMID: 21328525
Related Citations

Successful coordination and execution of nontherapeutic studies in a cooperative group setting: lessons learned from Children's Oncology Group studies.
Authors: Carter A. , Landier W. , Schad A. , Moser A. , Schaible A. , Hanby C. , Kurian S. , Wong F.L. , Villaluna D. , Bhatia S. .
Source: Cancer Epidemiology, Biomarkers & Prevention : A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology, 2008 Jul; 17(7), p. 1665-73.
PMID: 18628418
Related Citations